维普中文期刊产品整合服务

TGF-β signaling in aortic aneurysm: another round of controversy

查看全文 作  者:Fuyu Lin Xiao [1]Yang 高影响力作者 机构地区:[1]State Key Laboratory of Proteomics, Genetic Laboratory of Development and Diseases, Institute of Biotechnology, Beijing 100071, China高影响力机构 出  处:《Journal of Genetics and Genomics》索引2010年第37卷第9期,共9页高影响力期刊 基  金:supported by the grants from State Key Laboratory of Proteomics (No. SKLP-K200902);Chinese Key Program for Drug Invention (No. 2009ZX09501-027);Chinese National Key Program on Basic Research (Nos. 2005CB522506, 2006CB943501 and 2006BAI23B01-3) 摘  要:Aortic aneurysm (AA) is a common health problem with high mortality and no effective drugs. Transforming growth factor-β (TGF-β) superfamily members regulate various cellular processes, and TGF-β signaling has key roles in development, tissue homeostasis, and diseases. Interest in the role of TGF-β signaling in the pathogenesis of AAs has recently emerged, particularly since genetic studies demonstrated an association between gene mutations in components of TGF-β signaling and AAs. However, paradoxical discoveries have implicated dysregulated TGF-β signaling in aneurysm formation, complicating the precise functional role for TGF-β in aneurysm development and progression. Furthermore, interventions targeting towards TGF-β signaling using losartan, which may represent a suitable therapeutic option for AAs, were subject to skepticism especially because of conflicting experimental results obtained from TGF-β antibody treatment without knowledge of the underlying mechanism. We propose a TGF-β aneurysm paradox, which would provide a good opportunity for the development of genetic mouse models of AA. These models would be used to clarify the mechanisms underlying TGF-β signaling, which would translate into novel pharmacologic therapies based on the new molecular discoveries. 关 键 词:转化生长因子 动脉瘤 信号 发病机制 基因突变 小鼠模型 氨基酸 健康问题
相关文献

参考文献(52)

引证文献(3)

耦合文献(30)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费